CORC  > 金属研究所  > 中国科学院金属研究所
Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China
Zhong YuPing2; Zhang YiZhuo3; Liao AiJun4; Lil SuXia5; Tian Chen1; Lu Jin6
刊名Chinese Medical Journal
2017
卷号130期号:2页码:130-134
关键词Geriatric Assessment Medicine R Multicenter Study Multiple Myeloma
ISSN号0366-6999
其他题名Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China
英文摘要Background: Elderly multiple myeloma (MM) patients often tend to suffer a variety of diseases, so the treatment of choice is very difficult for the elderly myeloma patients. The overall survival (OS) time and side effects with elderly patients are unclear in China. The study tried to find out the role of geriatric assessment in the Chinese elderly MM. Methods: We retrospectively analyzed the data of 628 newly diagnosed patients from six hospitals from June 2011 to June 2013. A geriatric assessment had been performed to assess comorbidities, cognitive, and physical status for these patients. The primary endpoint was to evaluate different physical states of elderly patients with OS time and treatment-related side effects. Results: An additive scoring system (range: 0-5), based on age, Katz′s Activity of Daily Living (ADL) and Lawton′s Instrumental Activity of Daily Living (IADL) ≤5 and Charlson Comorbidity Index (CCI) was developed to identify three groups: fit (score = 0); intermediate-fitness (score = 1); and frail (score ≥2). The 3-year OS was 63% in fit patients, 63% in intermediate-fitness patients, and 49% in frail patients ≥3 hematologic adverse events (AEs) were documented in 45 (35.4%) fit, 34 (34%) intermediate-fitness, and 121 (30.2%) frail patients. The risk of a grade ≥3 hematologic AEs was not significantly increase in intermediate-fitness (hazard ratios HR: 0.99, 95% confidence interval CI: 0.54-1.47, P = 1.000) and in frail patients (HR: 1.16, 95% CI: 0.70-1.93, P = 0.558) compared with fit ones. Conclusions: MM occurs earlier in life and being advanced when the diagnosis is made in the mainland of China. The overall survival in frailty with International Staging System (ISS) II/III was the worst in all patients.
资助项目[National Natural Science Foundation of China]
语种英语
CSCD记录号CSCD:5900084
内容类型期刊论文
源URL[http://ir.imr.ac.cn/handle/321006/148193]  
专题金属研究所_中国科学院金属研究所
作者单位1.Peoples Liberat Army 304 Hosp, Department Hematol, Beijing 100048, Peoples R China
2.Beijing Univ, Clin Res Institute, Capital Med Univ, Dept Hematol,Beijing Chaoyang Hosp West, Beijing 100043, Peoples R China
3.中国科学院合肥物质科学研究院肿瘤医院
4.中国科学院金属研究所
5.Peoples Liberat Army 301 Hosp, Department Hematol, Beijing 100853, Peoples R China
6.北京大学
推荐引用方式
GB/T 7714
Zhong YuPing,Zhang YiZhuo,Liao AiJun,et al. Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China[J]. Chinese Medical Journal,2017,130(2):130-134.
APA Zhong YuPing,Zhang YiZhuo,Liao AiJun,Lil SuXia,Tian Chen,&Lu Jin.(2017).Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.Chinese Medical Journal,130(2),130-134.
MLA Zhong YuPing,et al."Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China".Chinese Medical Journal 130.2(2017):130-134.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace